1 results match your criteria: "The Second People's Hospital of Jinan City. yinchenghuaey@126.com[Affiliation]"
Zhongguo Zhong Xi Yi Jie He Za Zhi
April 2010
First Department of Internal Medicine, The Second People's Hospital of Jinan City.
Objective: To investigate the effect of Tongxinluo Capsule (TXLC) on platelet aggregation in patients of coronary heart disease (CHD) with aspirin resistance (AR).
Methods: Patients with AR were screened out from 330 CHD patients, who had regularly taken aspirin (100 mg/d) for more than one month, by testing platelet aggregation level after adenosine diphosphate (ADP) and collagen (COL) induction. They were randomly assigned to three groups: the combined treatment group treated by TXLC + aspirin, the TXL group treated by TXLC alone and the AS group treated by aspirin alone, at the dose of TXLC 3 capsules thrice a day, and that of aspirin 100 mg/d.